# OnCo record trisalus-life-sciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/trisalus-life-sciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "trisalus-life-sciences" ;
  schema:name "TriSalus Life Sciences"@en ;
  schema:alternateName "TriSalus Life Sciences, Inc."@en, "TriSalus"@en, "MedTech Acquisition Corp"@en ;
  schema:description "TriSalus makes catheter devices that push treatments into tumours in the liver and pancreas by controlling pressure and flow in the blood vessels. It is also testing an immune-stimulating drug, nelitolimod, given through those devices, in early trials."@en ;
  schema:url <https://onco.cc/companies/trisalus-life-sciences/>, <https://trisaluslifesci.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://trisaluslifesci.com/>, <https://trisaluslifesci.com/pipeline/>, <https://trisaluslifesci.com/drug-delivery-technology/>, <https://trisaluslifesci.com/candidate-nelitolimod/>, <https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001826667>, <https://www.orbimed.com/portfolio/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/uveal-melanoma/> ;
  onco:sections <https://onco.cc/fronts/surgery/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/nelitolimod/> .